{"schema_version":"secwatch.filing_event.v1","accession":"0001753926-25-000962","form_type":"8-K","ticker":"LIPO","cik":"0001347242","company_name":"LIPELLA PHARMACEUTICALS INC.","filed_at":"2025-06-16T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.041863+00:00","generated_at":"2026-05-19T06:11:06.686435+00:00","sec_items":["8.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"confidence":"high","headline":"Lipella sets 2025 annual meeting for July 21; record date June 18","bullets":["2025 annual meeting scheduled for July 21, 2025; record date for voting is June 18, 2025.","Stockholder proposals for inclusion in proxy must be received by June 18, 2025.","Deadline for director nominations and other business under advance notice bylaw is June 20, 2025.","Meeting date moved more than 30 days from 2024 annual meeting (Sept 10, 2024); change disclosed per Rule 14a-5(f)."],"urls":{"canonical":"https://secwatch.observer/filing/0001753926-25-000962","json":"https://secwatch.observer/filing/0001753926-25-000962.json","markdown":"https://secwatch.observer/filing/0001753926-25-000962.md","text":"https://secwatch.observer/filing/0001753926-25-000962.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1347242/000175392625000962/0001753926-25-000962-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1347242/000175392625000962/g084846_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T06:11:06.686435+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}